CTRI/2020/06/025928进行中（未招募）未知
Povidone Iodine Gargle and Intranasal application: A Quasi-Experimental study to reduce the spread of coronavirus infection in community with Covid-19 positive clusters.
Dr Sumita Shankar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1- Household (HH) contacts of laboratory confirmed COVID-19 case(s) (more than or equal to one case per HH)
- •2- Willing to carry out the procedures four times daily for 7 days if provided with the gargle solution.
- •3- Resident in the area for the last six months.
- •4- Persons willing to be part of this protocol and sign informed consent.
排除标准
- •1- Allergy (hypersensitivity) to povidone iodine.
- •2- Currently have or have ever had a thyroid problem, including swelling.
- •3- Pregnant women and lactating mothers.
- •4- Persons who are unable to carry out the intervention due to intellectual disability.
- •5- Persons who are too ill to participate.
研究者
相似试验
已完成
不适用
A novel drug combination and route for COVID-19 treatmentCorona virusPACTR202101875903773Hazem Elsersy200
终止
1 期
A phase I/II study of povidone-iodine nasal spray (Nasodine”) to investigate safety and tolerability in healthy volunteers (Stage 1), and to investigate safety and efficacy in patients with the common cold (Stage 2).Common ColdInfection - Other infectious diseasesACTRN12618001244291Firebrick Pharma Pty Ltd49
已完成
早期 1 期
Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort StudyChronic Rhinosinusitis (Diagnosis)NCT04097613St. Paul's Hospital, Canada29
已完成
2 期
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and InpatientsCOVID-19SARS-CoV 2NCT04364802Nikita Gupta98
Unknown
不适用
Povidone-Iodine Rinses as an Adjuvant Therapy Post-OperativelyChronic Rhinosinusitis (Diagnosis)NCT04278950St. Paul's Hospital, Canada100